Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update

$ACXPPress releaseOct 26, 2026, 8:01 AM ETRead the release

Acurx Pharmaceuticals announced it will discuss third quarter 2026 financial results on a conference call Thursday, November 12, 2026 at 8:00 a.m. ET, hosted by CEO David Luci and CFO Robert Shawah. The release contains no financial figures; it repeats that lead candidate ibezapolstat is Phase 3 ready for C.

Key figures

Call Date: 2026-11-12
Call Time: 8:00 a.m. ET

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.